User menu

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: Systematic review and meta-analysis

Bibliographic reference Lehert, Philippe ; Kolibianakis, Efstratios M. ; Venetis, Christos A. ; Schertz, Joan ; Saunders, Helen ; et. al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: Systematic review and meta-analysis. In: Reproductive Biology and Endocrinology, Vol. 12, no. 1 (2014)
Permanent URL
  1. Hill Micah J., Levy Gary, Levens Eric D., Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature, 10.1016/j.rbmo.2011.12.005
  2. Fischer Robert, Understanding the role of LH: myths and facts, 10.1016/s1472-6483(10)60375-6
  3. Sommer L., Zanger K., Dyong T., Dorn C., Luckhaus J., Diedrich K., Klingmuller D., Seven-day administration of the gonadotropin-releasing hormone antagonist Cetrorelix in normal cycling women, 10.1530/eje.0.1310280
  4. Doody Kevin, Devroey Paul, Gordon Keith, Witjes Han, Mannaerts Bernadette, LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles, 10.1016/j.rbmo.2009.12.019
  5. Ferraretti Anna Pia, Gianaroli Luca, Magli Maria C., D'angelo Arianna, Farfalli Valeria, Montanaro Nadia, Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques, 10.1016/j.fertnstert.2004.06.041
  6. Alviggi C, Mollo A, Clarizia R, Placido G De, Exploiting LH in ovarian stimulation, 10.1016/s1472-6483(10)60865-6
  7. Baruffi RLR, Mauri AL, Petersen CG, Felipe V, Martins AMC, Cornicelli J, Cavagna M, Oliveira JBA, Franco JG, Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis, 10.1016/s1472-6483(10)60758-4
  8. Kolibianakis E.M., Kalogeropoulou L., Griesinger G., Papanikolaou E.G., Papadimas J., Bontis J., Tarlatzis B.C., Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis, 10.1093/humupd/dmm008
  9. Oliveira João Batista A., Mauri Ana Lucia, Petersen Claudia G., Martins Anice M. C., Cornicelli João, Cavanha Mario, Pontes Anagloria, Baruffi Ricardo L. R., Franco José G., Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysis, 10.1007/s10815-006-9095-4
  10. Ferraretti A. P., La Marca A., Fauser B. C. J. M., Tarlatzis B., Nargund G., Gianaroli L., , ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria, 10.1093/humrep/der092
  11. Akobeng A K, Communicating the benefits and harms of treatments, 10.1136/adc.2008.137083
  12. Humaidan P, Bungum M, Bungum L, Yding Andersen C, Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study, 10.1016/s1472-6483(10)61643-4
  13. Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E, Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment, 10.1016/s1472-6483(10)60513-5
  14. Bosch Ernesto, Labarta Elena, Crespo Juana, Simón Carlos, Remohí José, Pellicer Antonio, Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis, 10.1016/j.fertnstert.2010.10.021
  15. Kyrou Dimitra, Kolibianakis Efstratios M., Venetis Christos A., Papanikolaou Evangelos G., Bontis John, Tarlatzis Basil C., How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis, 10.1016/j.fertnstert.2007.12.077
  16. Venetis Christos A., Kolibianakis Efstratios M., Tarlatzi Theoni B., Tarlatzis Basil C., Evidence-based management of poor ovarian response : Evidence-based management of poor ovarian response, 10.1111/j.1749-6632.2010.05665.x
  17. Kolibianakis E.M., Venetis C.A., Diedrich K., Tarlatzis B.C., Griesinger G., Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis, 10.1093/humupd/dmp026
  18. Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G, Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism, 10.1016/s1472-6483(10)60418-x
  19. Kailasam C., Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome, 10.1093/humrep/deh273
  20. Keay S. D., Liversedge N. H., Mathur R. S., Jenkins J. M., Assisted conception following poor ovarian response to gonadotrophin stimulation, 10.1111/j.1471-0528.1997.tb11525.x
  21. van Wely Madelon, Westergaard Lars G, Bossuyt Patrick M.M, van der Veen Fulco, Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis, 10.1016/s0015-0282(03)02187-3
  22. Hill Micah J., Levens Eric D., Levy Gary, Ryan Mary E., Csokmay John M., DeCherney Alan H., Whitcomb Brian W., The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis, 10.1016/j.fertnstert.2012.01.130
  23. Meniru G. I., Craft I. L., Utilization of retrieved oocytes as an index of the efficiency of superovulation strategies for in-vitro fertilization treatment, 10.1093/humrep/12.10.2129
  24. LANE D, VITTINGHOFF E, CROUGHAN M, CEDARS M, FUJIMOTO V, Gonadotropin stimulation demonstrates a ceiling effect on in vitro fertilization outcomes, 10.1016/j.fertnstert.2005.11.057
  25. YIH M, SPANDORFER S, ROSENWAKS Z, Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories, 10.1016/j.fertnstert.2004.05.096
  26. Stern Judy E., Goldman Marlene B., Hatasaka Harry, MacKenzie Todd A., Surrey Eric S., Racowsky Catherine, Optimizing the number of cleavage stage embryos to transfer on day 3 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study, 10.1016/j.fertnstert.2007.12.051
  27. Sunkara Sesh Kamal, Rittenberg Vivian, Raine-Fenning Nick, Bhattacharya Siladitya, Zamora Javier, Coomarasamy Arri, Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles, 10.1093/humrep/der106
  28. Stoop D., Ermini B., Polyzos N. P., Haentjens P., De Vos M., Verheyen G., Devroey P., Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles, 10.1093/humrep/des131
  29. Lukaszuk Krzysztof, Kunicki Michał, Liss Joanna, Lukaszuk Mariusz, Jakiel Grzegorz, Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization, 10.1016/j.ejogrb.2013.01.013
  30. Bosch Ernesto, Ezcurra Diego, Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients, 10.1186/1477-7827-9-82
  31. Oudendijk J.F., Yarde F., Eijkemans M.J.C., Broekmans F.J.M., Broer S.L., The poor responder in IVF: is the prognosis always poor? A systematic review, 10.1093/humupd/dmr037
  32. Lexchin J., Pharmaceutical industry sponsorship and research outcome and quality: systematic review, 10.1136/bmj.326.7400.1167
  33. Balasch Juan, Creus Montserrat, Fábregues Francisco, Civico Salvadora, Carmona Francisco, Puerto Bienvenido, Casamitjana Roser, Vanrell Juan A., 10.1023/a:1016662100572
  34. Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe GP, Picconeri MG, Campbell A, Use of recombinant LH in a group of unselected IVF patients, 10.1016/s1472-6483(10)61610-0
  35. Sauer Mark V, Thornton Melvin H, Schoolcraft William, Frishman Gary N, Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction, 10.1016/s1472-6483(10)61631-8
  36. Cedrin-Durnerin I., Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study, 10.1093/humrep/deh369
  37. Griesinger G., Schultze-Mosgau A., Dafopoulos K., Schroeder A., Schroer A., von Otte S., Hornung D., Diedrich K., Felberbaum R., Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol, 10.1093/humrep/deh741
  38. Levi-Setti Paolo E., Cavagna Mario, Bulletti Carlo, Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: Comparison of r-FSH alone and in combination with r-LH, 10.1016/j.ejogrb.2005.11.023
  39. Fábregues Francisco, Creus Montserrat, Peñarrubia Joana, Manau Dolors, Vanrell Juan A., Balasch Juan, Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age, 10.1016/j.fertnstert.2005.09.049
  40. Ruvolo Giovanni, Bosco Liana, Pane Antonina, Morici Giovanni, Cittadini Ettore, Roccheri Maria C., Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures, 10.1016/j.fertnstert.2006.06.059
  41. Berkkanoglu Murat, Isikoglu Mete, Aydin Donay, Ozgur Kemal, Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders, 10.1016/j.fertnstert.2006.11.150
  42. Barrenetxea Gorka, Agirregoikoa Jon Ander, Jiménez María Rosario, Lopez de Larruzea Arantza, Ganzabal Teresa, Carbonero Koldo, Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles, 10.1016/j.fertnstert.2007.03.088
  43. Pezzuto Antonio, Ferrari Bruno, Coppola Francesco, Nardelli Giovanni Battista, LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels, 10.3109/09513590903215516
  44. Gutman Guy, Barak Vivian, Maslovitz Sharon, Amit Ami, Lessing Joseph B., Geva Eli, Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity, 10.1016/j.fertnstert.2008.02.006
  45. Matorras R, Prieto B, Exposito A, Mendoza R, Crisol L, Herranz P, Burgués S, Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study, 10.1016/j.rbmo.2009.09.016
  46. Kovacs Peter, Kovats Timea, Kaali Steven G., Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization, 10.1016/j.fertnstert.2008.12.010
  47. Musters A. M., van Wely M., Mastenbroek S., Kaaijk E. M., Repping S., van der Veen F., Mochtar M. H., The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve, 10.1093/humrep/der371
  48. Caserta Donatella, Lisi Franco, Marci Roberto, Ciardo Francesca, Fazi Alessandra, Lisi Roberta, Moscarini Massimo, Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?, 10.3109/09513590.2010.544133